Acting On Nitrogen-containing Compound As Donor (1.2, 1.5, 1.7) Patents (Class 435/191)
  • Patent number: 5314542
    Abstract: A culture of Nitrosomonas packaged in a manner to induce a metabolic state of dormancy under conditions favorable for survival of up to at least one year at room temperature: with a method for its rapid reactivation to complete metabolic activity within about 72 hours: for its subsequent addition into aquaria to immediately begin the oxidation and prevention of harmful ammonia accumulation.
    Type: Grant
    Filed: August 6, 1993
    Date of Patent: May 24, 1994
    Assignee: Precision Aquarium Testing, Inc.
    Inventors: Edward J. Cassidy, Ronald D. Jones
  • Patent number: 5296358
    Abstract: The enzymatic preparation of cephalosporanic derivatives, or their salts, ving the formula: ##STR1## wherein R is --CO--COOH or --COOH, R.sub.1 is H, OH, or --O--CO--R" and R" is an alkyl group with 1 to 4 carbon atoms, is carried out by the oxidative deamination of compounds, or their salts, having the formula: ##STR2## with an oxidase D-Aminoacid enzyme derived from Rhodotorula glutinis NCIMB 40412. The enzyme can be in a free or immobilized form.
    Type: Grant
    Filed: June 3, 1992
    Date of Patent: March 22, 1994
    Assignee: Ministero Dell'Universita' e Della Ricerca Scientifica e Tecnologica
    Inventors: Ezio A. Battistel, Pietro Cesti, Giuliana Franzosi, Vilhelmus van der Goes, Silvana Bonicelli, Mirella Pilone
  • Patent number: 5290690
    Abstract: The invention pertains to a method for the production of a biologically active modified protein derived from a starting protein having essentially the same kind of biological activity with an attendant modulation effect on, particularly increase of, the stability as compared with that of the starting protein. The method comprises substituting an arginine residue for a lysine residue of the starting protein at a site that can sterically accommodate the substitution, without substantially altering the biological activity of the starting protein, said site being preferably of low solvent accessibility, at interfaces between domains or sub-units of the starting protein.
    Type: Grant
    Filed: August 25, 1989
    Date of Patent: March 1, 1994
    Assignees: Plant Genetic Systems, Gist-brocades
    Inventors: Nadir Mrabet, Ignace Lasters, Patrick Stanssens, Gaston Matthyssens, Shoshana Wodak, Wilhelmus J. Quax
  • Patent number: 5284754
    Abstract: A process for the continuous conversion of cephalosporin derivatives into glutaryl-7-aminocephalosporanic acid derivativesA process for the continuous conversion of cephalosporin derivatives into the corresponding glutaryl-7-aminocephalosporanic acid derivatives in the presence of a catalyst containing D-amino-acid oxidase is described. The product yield can be increased, where appropriate, by addition of hydrogen peroxide.
    Type: Grant
    Filed: September 3, 1991
    Date of Patent: February 8, 1994
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Thomas Bayer, Klaus Sauber
  • Patent number: 5278043
    Abstract: Energy-transfer systems which can be used, inter alia, for measuring distances within or between different molecules are described, comprising derivatives of lumazine and ruthenium, in particular derivatives of DNA or RNA sequences.
    Type: Grant
    Filed: January 22, 1991
    Date of Patent: January 11, 1994
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Wilhelm Bannwarth, Francis Muller
  • Patent number: 5272054
    Abstract: A method of assay for isotopically exchangeable analytes is disclosed. Analytes are labeled by enzymatic exchange of a hydrogen atom of the analyte and a deuterium or tritium atom. Preferably, analytes are labeled by reaction with an oxidant, a reducing agent which contains a deuterium or tritium atom, and an enzyme capable of catalyzing the reversible exchange of a hydrogen atom between the analyte, the oxidant, and the reducing agent. Kits for conveniently performing the assay methods are also disclosed.
    Type: Grant
    Filed: March 26, 1992
    Date of Patent: December 21, 1993
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Arthur C. Switchenko, Edwin F. Ullman
  • Patent number: 5272077
    Abstract: A method is provided for preparing a covalent conjugate of an oligonucleotide and an enzyme, such as peroxidase. This conjugate can be used as a probe in hybridization assays and in polymerase chain reaction procedures. The method generally comprises the steps of: reacting an enzyme having a reactive amino group with a mercapto-substituted organic compound to form a blocked intermediate, removing the blocking group to form an enzyme reagent, and reacting the enzyme reagent with a functionalized oligonucleotide reagent.
    Type: Grant
    Filed: May 10, 1993
    Date of Patent: December 21, 1993
    Assignee: Eastman Kodak Company
    Inventors: Harold C. Warren, III, Fred T. Oakes
  • Patent number: 5270179
    Abstract: The present invention discloses a recombinant DNA molecule having a full length or a truncated T5 DNA polymerase structural gene, each encoding a processive, thioredoxin-independent DNA polymerase. The DNA polymerase of the invention may have 3'-to-5'exonuclease activity or may be substantially reduced in processive 3'-to-5'DNA exonuclease activity. A method for producing these enzymes is also disclosed, as is the proteins produced by this process. The present invention is also directed to a leader sequence important for expression of soluble T5 DNA polymerase protein.
    Type: Grant
    Filed: January 28, 1992
    Date of Patent: December 14, 1993
    Assignee: Life Technologies, Inc.
    Inventor: Deb K. Chatterjee
  • Patent number: 5266472
    Abstract: This invention relates to a process for stabilizing the enzyme urate oxidase (commonly known as uricase) in liquid form, and to the relative compositions which can then be obtained, with particular reference to compositions containing a Trinder reagent. According to the process of the invention, uricase can be stabilized in liquid form by adding to the composition containing the enzyme a substituted or unsubstituted dicarboxylic acid containing from 2 to 5 carbon atoms, and preferably 4 or 5. Aspartic acid has shown to be particularly effective in providing said stabilizing activity in liquid uricase compositions containing a Trinder reagent.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: November 30, 1993
    Assignee: Instrumentation Laboratory S.R.L.
    Inventors: Maurizio D'Alterio, Dario Frontini, Mauro Papagni
  • Patent number: 5262304
    Abstract: A method for optical measurement of bilirubin which comprises reacting a bilirubin-containing sample with a zinc compound, a coloring agent and bilirubin oxidase in a buffer, wherein a stable green pigment having a large molecular extinction coefficient is formed by the action of the zinc compound and thereby bilirubin in the sample can be measured specifically, and a reagent useful therefor. Said method and the reagent are useful for clinical test of total bilirubin and direct bilirubin in serum.
    Type: Grant
    Filed: December 18, 1990
    Date of Patent: November 16, 1993
    Assignee: Nippon Shoji Kabushiki Kaisha
    Inventor: Seiichi Taniguchi
  • Patent number: 5258501
    Abstract: A process for the preparation of stabilized glycoproteins without the introduction of foreign molecules. Susceptible monosaccharides covalently attached to the protein part of the molecule undergo periodate oxidation and, after elimination of the remaining periodate, the oxidized glycoprotein is incubated in a buffer under conditions favorable for the reaction between the aldehyde groups generated in the sugar part and the amino acid residues from the protein part. The oxidized carbohydrate chains act as a polyaldehyde crosslinker, with the cross-linking reaction producing intramolecularly and intermolecularly linked derivatives. The amount and size of the intermolecularly linked derivatives are controlled by degree of oxidation and protein concentration. The thermal stability, depends on the degree of oxidation and under optimal conditions is about 10 times better than the stability of native invertase.
    Type: Grant
    Filed: March 2, 1992
    Date of Patent: November 2, 1993
    Inventors: Slobodan Barbaric, Branko Kozulic
  • Patent number: 5254469
    Abstract: A covalent conjugate of an enzyme, such as peroxidase, glucose oxidase, alkaline phosphatase and beta-galactosidase, and an oligonucleotide is herein disclosed. This conjugate can be used as a probe in hybridization assays and in polymerase chain reaction procedures.
    Type: Grant
    Filed: September 17, 1991
    Date of Patent: October 19, 1993
    Assignee: Eastman Kodak Company
    Inventors: Harold C. Warren, III, Fred T. Oakes
  • Patent number: 5252468
    Abstract: A process for producing deacetylase which comprises incubating a deacetylase-producing bacterium belonging to Vibrio cholerae in a IFO 15429 culture medium containing a carbon source, a nitrogen source, an inorganic salt and an inducer for producing the deacetylase and isolating the deacetylase from cells separated from said culture medium.
    Type: Grant
    Filed: February 26, 1992
    Date of Patent: October 12, 1993
    Assignee: Agency of Industrial Science & Technology
    Inventors: Shizu Fujishima, Fumiko Yaku, Ryutarou Tanaka, Einosuke Muraki, Naoko Yamano
  • Patent number: 5245023
    Abstract: A method for controlling and modifying biopolymer synthesis by manipulation of the genetics and enzymology of synthesis of polyhydroxybutyrate (PHB) and polyhydroxyalkanoate (PHA) polyesters at the molecular level in procaryotic and eukaryotic cells, especially plants. Examples demonstrate the isolation, characterization, and expression of the genes involved in the production of PHB and PHA polymers. Genes encoding the enzymes in the PHB and PHA synthetic pathway (beta-ketothiolase, acetoacetyl-CoA reductase and PHB polymerase or PHA polymerase) from Zoogloea ramigera strain I-16-M, Alcaligenes eutrophus, Nocardia salmonicolur, and Psuedomonas olevarans were identified or isolated and expressed in a non-PHB producing organism, E. coli. Specific modifications to the polymers include variation in the chain length of the polymers and incorporation of different monomers into the polymers to produce co-polymers with different physical properties.
    Type: Grant
    Filed: May 8, 1991
    Date of Patent: September 14, 1993
    Assignee: Massachusetts Institute of Technology
    Inventors: Oliver P. Peoples, Anthony J. Sinskey
  • Patent number: 5229279
    Abstract: The present invention invention is a method for controlling biopolymer synthesis by determining the genetics and enzymology of polyhydroxybutyrate (PHB) biosynthesis at the molecular level. The purified enzymes and genes provide the means for developing new PHB-like biopolymers having polyester backbones. Specific aims are to 1) control the chain length of the polymers produced in fermentation processes through genetic manipulation, 2) incorporate different monomers into the polymers to produce copolymers with different physical properties, and 3) examine the physical/ rheological properties of these new biopolymers in order to develop further design criteria at the molecular level.
    Type: Grant
    Filed: August 13, 1990
    Date of Patent: July 20, 1993
    Assignee: Massachusetts Institute of Technology
    Inventors: Oliver P. Peoples, Anthony J. Sinskey
  • Patent number: 5221289
    Abstract: A dyed textile article treated with tannic acid and dyed with an extract of mycelia or basidiocarps of Ganoderma lucidum. This article is produced by a process comprising contacting a substrate article of cotton, linen, silk or wool first with a pretreating bath containing tannic acid or a natural material containing tannic acid, e.g. gall, then with a mordant bath containing an alumina mordant, such as grass or wood ashes, and finally with the mycelia or basidiocarps of Ganoderma lucidum. This dyed textile article has not only a natural color and feeling, with a sufficient depth of color, but also antimicrobial and antiallergic functions.
    Type: Grant
    Filed: June 25, 1992
    Date of Patent: June 22, 1993
    Assignee: Hiroki Miyamatsu
    Inventors: Hiroki Miyamatsu, Okihiro Kawai, Koji Morita, Michinori Kubo
  • Patent number: 5208155
    Abstract: A Triqonopsis variabilis D-amino acid oxidase in substantially pure form and active against cephalosporin C is disclosed. This D-amino acid oxidase is isolated from Trigonopsis variabilis by a method which is performed in three steps, namely:(a) acidifying and heating a crude cell extract of Trigonopsis variabilis to obtain a precipitate and supernatant fraction;(b) treating said supernatant fraction obtained in step (a) with sufficient ammonium sulfate to obtain a second precipitate, said second precipitate containing the D-amino acid oxidase of claim 1; and(c) resuspending the precipitate obtained in step (b) and collecting the D-amino acid oxidase by isoelectric precipitation.
    Type: Grant
    Filed: June 19, 1992
    Date of Patent: May 4, 1993
    Inventors: Klaus Mosbach, Estera Szwajcer
  • Patent number: 5188941
    Abstract: The present invention provides a new methodology and test composition for determining the presence of theophylline in test samples. The methodology employs enzymes that utilize or recognize theophylline as a substrate to measure the concentration thereof in samples, including body fluids. This new approach utilizes enzymes as opposed to traditional methods which use antibodies for the recognition of theophylline. The enzymatic approach to theophylline determination is quick, simple and convenient and allows test systems to be made in liquid as well as in dry-chemistry formats. Various protocols, systems or methodologies may be used for assaying and relating the results to the amount of theophylline present. Methods for obtaining theophylline utilizing or recognizing enzymes are also described.
    Type: Grant
    Filed: December 31, 1991
    Date of Patent: February 23, 1993
    Assignee: GDS Technology, Inc.
    Inventors: Aurora F. deCastro, Surendra K. Gupta, Arun K. Agarwal
  • Patent number: 5187088
    Abstract: A novel choline oxidase being thermostable at 50.degree. C. at pH 7 to 9 is disclosed. A method for producing the enzyme by using actinomycetes is also disclosed.
    Type: Grant
    Filed: September 5, 1991
    Date of Patent: February 16, 1993
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Itsuo Furuoya, Takashi Suzuki, Takeshi Takahashi
  • Patent number: 5185257
    Abstract: A new thermostable xanthine oxidase obtained from a microbe belonging to the genus Arthrobacter and a method of its production are disclosed. The present invention affords a xanthine oxidase which is excellent in thermal stability and which retains at least 70% residual activity after heat treatment at 60.degree. C. for 30 minutes. Arthrobacter luteus ATCC 21606 is the preferred microbe. The enzyme has a molecular weight of about 160,000 daltons as determined by gel filtration and a pH optimum of about 7.5.
    Type: Grant
    Filed: April 16, 1991
    Date of Patent: February 9, 1993
    Assignee: Toyo Boseki Kabushiki Kaisha
    Inventors: Naoko Tanigaki, Kayoko Furukawa, Yukihiro Sogabe, Shigenori Emi
  • Patent number: 5179013
    Abstract: Novel cytochrome P-450.sub.sca-1, P-450.sub.sca-2 and P-450.sub.sca-3 enzymes are produced by cultivation of Streptomyces carbophilus SANK 62585, and are suitable for use in hydroxylation processes.
    Type: Grant
    Filed: May 30, 1990
    Date of Patent: January 12, 1993
    Assignee: Sankyo Company, Limited
    Inventors: Tatsuji Matsuoka, Shunichi Miyakoshi
  • Patent number: 5169758
    Abstract: The present invention provides a stabilized, NAD(P)H-dependent, soluble nitrate reductase of the assimilatory type, characterized by a molecular weight of about 90,000 D in the case of electrophoresis in the presence of sodium dodecyl sulphate and a residual activity after 3 weeks at 35.degree. C. of more than 60%, obtainable by preparing a suspension of the comminuted starting material in tris/tartaric acid buffer (pH 7-8.5), adding soluble polyethyleneimine thereto in such an amount that 10 to 20% of the nitrate reductase activity passes into the precipitation obtained, separating off the precipitate and working up the supernatant according to conventional biochemical methods of fractionation in the above-mentioned digestion buffer, dialyzing the enzyme solution obtained and lyophilizing in a zwitterionic buffer.
    Type: Grant
    Filed: August 1, 1990
    Date of Patent: December 8, 1992
    Assignee: Boehringer Mannheim GmbH
    Inventors: Stephan Fischer, Barbel Wurst, Hans-Otto Beutler, Georg-Burkhard Kresse, Herwig Brunner
  • Patent number: 5153138
    Abstract: The present invention provides a pyruvate oxidase which decarboxylates pyruvate to form inter alia hydrogen peroxide and is active without the addition of FAD, thiamine pyrophosphate and divalent metal ions. The amino acid sequence of the enzyme changes at least one proline in position 178 and alanine in position 458 to a different amino acid. The present invention also provides a process for the preparation of this pyruvate oxidase and methods of use thereof.
    Type: Grant
    Filed: July 26, 1991
    Date of Patent: October 6, 1992
    Assignee: Boehringer Mannheim GmbH
    Inventors: Gunther Schumacher, Hans Moellering
  • Patent number: 5149636
    Abstract: Multiple copies of a foreign DNA I coding for the production of a protein may be introduced into eucaryotic cells by cotransforming suitable cells with foreign DNA I and with foreign DNA II which includes a functionally deficient, amplifiable gene coding for a selectable or identifiable trait, preferably carried on the same DNA molecule as a foreign DNA III, which includes a functional, amplifiable gene coding for another selectable or identifiable trait. The cotransformation is carried out under suitable conditions permitting selection or identification of cells expressing the gene on DNA I or that on DNA III, but not that on DNA II. The cotransformed cells so identified or selected are recovered and cloned under conditions where the functionally deficient gene on DNA II is expressed. Cells expressing the gene on DNA II are recovered. They contain multiple copies of DNA I. This method can be used to produce mRNA transcripts or protein products such as human and animal growth hormone, insulin and the like.
    Type: Grant
    Filed: September 26, 1988
    Date of Patent: September 22, 1992
    Assignee: Trustees of Columbia University in the City of New York
    Inventors: Richard Axel, James M. Roberts
  • Patent number: 5143828
    Abstract: A method for synthesizing enzyme-catalyzed polymers using the Langmuir-Blodgett technique. In one embodiment, the process comprises spreading one or more enzyme-polymerizable monomers on a water-miscible solvent. The monomers are sufficiently surface active that they align themselves on the air-solvent interface. Next, pressure is applied to the interface to form a monolayer made up of the monomers. An enzyme is then introduced into the solvent, causing polymerization of the monomers in the monolayer. The polymeric monolayers produced by the present method are easier to process and have reduced cross-linking and branching as compared to similar polymers produced in bulk by enzyme-catalyzed reactions.
    Type: Grant
    Filed: December 31, 1991
    Date of Patent: September 1, 1992
    Assignees: The United States of America as represented by the Secretary of the Army, University of Massachusetts Lowell
    Inventors: Joseph A. Akkara, David L. Kaplan, Lynne A. Samuelson, Braja K. Mandal, Sukant K. Tripathy, Ferdinando F. Bruno, Kenneth A. Marx
  • Patent number: 5098836
    Abstract: In a process for polymerizing monomers with free-radical initiators in aqueous solution to produce polymers useful in oil field applications, wherein said polymerization process employs an oxygen-scavenging agent, the improvement which comprises employing said oxygen scavenging agent and oxidase enzyme with a substrate therefor, optionally with a catalase, such as alcohol oxidase and methanol, to consume dissolved oxygen in a polymerization admixture. Oxygen-scavenging under field conditions with the oxidase/substrate system permits consistent production conveniently of water based polymer solutions of good viscosity for oil field applications.
    Type: Grant
    Filed: August 14, 1989
    Date of Patent: March 24, 1992
    Assignee: Phillips Petroleum Company
    Inventors: G. Allan Stahl, Thomas R. Hopkins
  • Patent number: 5096821
    Abstract: The present invention provides a pyruvate oxidase which decarboxylates pyruvate to form inter alia hydrogen peroxide and is active without the addition of FAD, thiamine pyrophosphate and divalent metal ions. The amino acid sequence of the enzyme changes at least one proline in position 178 and alanine in position 458 to a different amino acid. The present invention also provides a process for the preparation of this pyruvate oxidase and methods of use thereof.
    Type: Grant
    Filed: March 14, 1991
    Date of Patent: March 17, 1992
    Assignee: Boehringer Mannheim GmbH
    Inventors: Gunther Schumacher, Hans Moellering
  • Patent number: 5094943
    Abstract: The present invention provides a process for the improved colorimetric determination of hydrogen peroxide as formed by a hydrogen peroxide-producing oxidase, by addition of a chromogenic system and measurement of the colored material formed, wherein superoxide dismutase (E.C. 1.15.1.1) is added to the reagent solution.The present invention also provides a reagent for the improved colorimetric determination of hydrogen peroxide, comprising a hydrogen peroxide-producing oxidase, a chromogenic system, a buffer and optionally adjuvant enzymes, wherein it also contains superoxide dismutase.
    Type: Grant
    Filed: January 19, 1988
    Date of Patent: March 10, 1992
    Assignee: Boehringer Mannheim GmbH
    Inventors: Joachim Siedel, Albert Roder, Joachim Ziegenhorn
  • Patent number: 5091312
    Abstract: This invention relates to a process of producing sarcosine oxidase by cultivating microorganisms belonging to genus Streptomyces and possessing an ability to produce sarcosine oxidase, and collecting sarcosine oxidase from the obtained culture. As an example of said microorganisms used in this invention, Streptomyces sp. KB210-8SY discovered by the prevent inventor is known.Said microorganisms are cultivated usually by using a culture medium, and from the obtained culture, sarcosine oxidase is isolated and purified.
    Type: Grant
    Filed: October 16, 1990
    Date of Patent: February 25, 1992
    Assignee: Kobayashi Pharmaceutical Co., Ltd.
    Inventors: Hiroya Iwasaki, Katsuyuki Fujimura, Yoshio Inoue, Shoshiro Nakamura
  • Patent number: 5089393
    Abstract: Ethanolamine in a sample can be assayed by treating the sample with ethanolamine oxidase, thereby to catalyze a reaction-consuming ethanolamine, oxygen and water, and forming glycolaldehyde, ammonia and hydrogen peroxide. The amount of consumed oxygen or the amount of generated ammonia or hydrogen peroxide is then determined, as a measure of the ethanolamine that was originally the sample. The ethanolamine can appear in the sample as such, or can be liberated simultaneously with or prior to the catalysis reaction, from an ethanolamine derivative, e.g. phosphatidyl ethanolamine by the action of phospholipase D. Ethanolamine oxidase can be produced from Bacillus sp. B-0783 FERM-P No. 5798 in a conventional culture medium, preferably by submerged aeration liquid culturation.
    Type: Grant
    Filed: March 31, 1988
    Date of Patent: February 18, 1992
    Assignee: Toyo Jozo Kabushiki Kaisha
    Inventors: Shigeyuki Imamura, Hideo Misaki
  • Patent number: 5082780
    Abstract: A covalent conjugate of an enzyme, such as peroxidase, glucose oxidase, alkaline phosphatase and beta-galactosidase, and an oligonucleotide is herein disclosed. This conjugate can be used as a probe in hybridization assays and in polymerase chain reaction procedures.
    Type: Grant
    Filed: September 12, 1989
    Date of Patent: January 21, 1992
    Assignee: Eastman Kodak Company
    Inventors: Harold C. Warren, III, Fred T. Oakes
  • Patent number: 5079157
    Abstract: A novel choline oxidase being thermostable at 50.degree. C. at pH 7 to 9 is disclosed. A method for producing the enzyme by using actinomycetes is also disclosed.
    Type: Grant
    Filed: August 25, 1989
    Date of Patent: January 7, 1992
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Itsuo Furuoya, Takashi Suzuki, Takeshi Takahashi
  • Patent number: 5024945
    Abstract: The present invention provides a process for obtaining sarcosine oxidase from micro-organisms by culturing thereof and obtaining the enzyme from the biomass or from the culture broth, wherein a Pseudomonas strain is cultured.
    Type: Grant
    Filed: July 10, 1984
    Date of Patent: June 18, 1991
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ulrich Mayr, Helmgard Gauhl, Hans Seidel
  • Patent number: 4987076
    Abstract: Different from conventional uricase products, the uricase of the present invention has outstandingly high thermal stability and is active in a wide range of pH from 5 to 10 for the oxidative decomposition of uric acid undertaken in clinical analysis. The uricase of the invention is produced microbiologically by a thermophilic microorganism belonging to the genus of Bacillus and especially named as Bacillus sp. TB-90 which is a novel species distinguishable from any of the microorganisms belonging to the genus of Bacillus.
    Type: Grant
    Filed: August 9, 1989
    Date of Patent: January 22, 1991
    Assignee: Sapporo Breweries Limited
    Inventors: Masachika Takashio, Takahide Chikano, Minoru Kamimura
  • Patent number: 4965196
    Abstract: A method for controlled production of a desired mature protein in a vertebrate host cell through the use of a polycistronic expression vector, which contains sequences coding for the desired protein and a secondary protein, is described. Both coding sequences are governed by the same promoter and are separated by translational stop and start signal codons. The expression of the secondary sequence effects control over the expression of the sequence coding for the desired protein, and the secondary protein functions as a marker for selection of transfected cells.
    Type: Grant
    Filed: September 24, 1987
    Date of Patent: October 23, 1990
    Assignee: Genentech, Inc.
    Inventors: Arthur D. Levinson, Christian Simonsen
  • Patent number: 4954445
    Abstract: NAD(P)H oxidase is disclosed having the following enzymological properties:(1) ActionIt oxidizes NADH or NADPH in the presence of oxygen to form NAD or NAD and hydrogen peroxide.NAD(P)H+H.sup.+ +O.sub.2 .fwdarw.NAD(P).sup.+ +H.sub.2 O.sub.2(2) Substrate specificityIt acts upon NADH and NADPH.(3) Optimum pHIts optimum pH lies in the range of about 9 to 10.Also disclosed is a process for producing the NAD(P)H oxidase and a method for determining the quantity of substrate or enzyme activity in a sample solution by utilizing a reaction system forming NADH or NADPH.
    Type: Grant
    Filed: August 11, 1987
    Date of Patent: September 4, 1990
    Assignee: Takara Shuzo Co., Ltd.
    Inventors: Yoshio Yoshihama, Asuka Kagaya, Susumu Matsui, Akira Obayashi
  • Patent number: 4929551
    Abstract: The invention relates to a process for producing L(-)-tetrahydrofolic acid which comprises allowing dihydrofolate reductase to act upon dihydrofolic acid in the presence of (1) NADP or NADPH, and (2) glucose and glucose dehydrogenase. L(-)-tetrahydrofolic acid is useful as the intermediate for L(-)-leucovarin.
    Type: Grant
    Filed: August 15, 1989
    Date of Patent: May 29, 1990
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Tamotsu Eguchi, Takashi Oshiro, Yukihiro Kuge, Kenichi Mochida, Takayuki Uwajima
  • Patent number: 4927760
    Abstract: Both the ease and cost of isolating the water insoluble orange pigment produced as a secondary metabolite by Monascus species can be substantially improved by inducing crystalline pigment formation directly in the culture medium. Poly(oxyethylene)sorbitan esters of palmitic acid are especially effective and cause the formation of large crystals. Another class of crystalline pigment inducing agents is that of the liquid vegetable oils, although generally these lead to smaller crystal sizes.
    Type: Grant
    Filed: June 15, 1989
    Date of Patent: May 22, 1990
    Assignee: UOP
    Inventor: Edward J. St. Martin
  • Patent number: 4923811
    Abstract: A process for carrying out enzymatic oxidations is described.
    Type: Grant
    Filed: August 28, 1987
    Date of Patent: May 8, 1990
    Assignee: BASF Aktiengesellschaft
    Inventors: Helmut Simon, Helmut Guenther
  • Patent number: 4914028
    Abstract: A process for preparing .beta.-2',2'-difluoronucleosides, and a novel intermediate thereto, are disclosed.
    Type: Grant
    Filed: February 10, 1988
    Date of Patent: April 3, 1990
    Assignee: Eli Lilly and Company
    Inventors: Larry W. Hertel, Cora Sue Grossman, Julian S. Kroin
  • Patent number: 4908313
    Abstract: In a process for hydrating a nitrile compound by the action of a microorganism having nitrilase activity to convert the nitrile compound into the corresponding amide compound, the performances such as yield and reaction velocity are markedly enhanced by irradiation of the microorganism with light. The process of the present invention is characterized in that (a) the microorganism having nitrilase activity is a positive gram-staining microorganism, (b) the microbial cells are allowed to accept light energy of at least about 1.times.10.sup.-2 .mu.E/g microbial cells second before termination of the hydration reaction, and (c) the hydration reaction is carried out in a vessel composed at least partly of a non-light transmitting material.
    Type: Grant
    Filed: December 10, 1987
    Date of Patent: March 13, 1990
    Assignee: Nitto Kagaku Kogyo Kabushiki Kaisha
    Inventors: Yoshiaki Satoh, Yasutaka Nakashima, Kanehiko Enomoto, Atsushi Fujiwara, Toshiaki Doi
  • Patent number: 4904602
    Abstract: The subject invention concerns a novel enzyme named thioredoxin shufflease, means for preparing the same, and procedures for using thioredoxin shufflease to fold proteins containing disulfide crosslinks. Thioredoxin shufflease is a generic term to define enzymes which have the following characteristics: (a) contain a single reactive thiol group; (b) catalyze the exchange of disulfides in a protein undergoing the refolding process; and (c) are not consumed in the oxidation/refolding process. Specifically exemplified is a thioredoxin shufflease produced from an E. coli thioredoxin gene.
    Type: Grant
    Filed: August 8, 1986
    Date of Patent: February 27, 1990
    Assignee: Repligen Corporation
    Inventors: Vincent P. Pigiet, James R. Rusche, Barbara J. Schuster
  • Patent number: 4882280
    Abstract: Different from conventional uricase products, the uricase of the present invention has outstandingly high thermal stability and is active in a wide range of pH from 5 to 10 for the oxidative decomposition of uric acid undertaken in clinical analysis. The uricase of the invention is produced microbiologically by a thermophilic microorganism belonging to the genus of Bacillus and especially named as Bacillus sp. TB-90 which is a novel species distinguishable from any of the microorganisms belonging to the genus of Bacillus.
    Type: Grant
    Filed: May 22, 1986
    Date of Patent: November 21, 1989
    Assignee: Sapporo Breweries Limited
    Inventors: Masachika Takashio, Takahide Chikano, Minoru Kamimura
  • Patent number: 4826766
    Abstract: This invention relates to a process for producing a desired alpha-amino acid, AA.sub.d, or a derivative thereof. The process comprises:(a) reacting a first alpha-amino acid, AA.sub.NH.sbsb.2 ; a first alpha-keto acid, KA.sub.t ; a second alpha-keto acid, KA.sub.pre ; a first transaminase enzyme and a second transaminase enzyme to produce (i) the desired alpha-amino acid, AA.sub.d and (ii) a third alpha-keto acid, KA.sub.prod ; and(b) removing KA.sub.prod from the other keto acids, amino acids and enzymes wherein AA.sub.d and KA.sub.pre, AA.sub.t and KA.sub.t, and AA.sub.NH.sbsb.2 and KA.sub.prod are interconvertible, respectively, by amino group transfer. The first transaminase efficiently catalyzes reaction (i), but not reaction (ii) and the second transaminase efficiently catalyzes reaction (ii) but not reaction (i):AA.sub.NH.sbsb.2 +KA.sub.t .revreaction.AA.sub.t +KA.sub.prod (i)AA.sub.t +KA.sub.pre .revreaction.AA.sub.d +KA.sub.t (ii)In one embodiment KA.sub.
    Type: Grant
    Filed: September 23, 1985
    Date of Patent: May 2, 1989
    Assignee: Genetics Institute, Inc.
    Inventor: J. David Rozzell
  • Patent number: 4810648
    Abstract: Nitrilase enzymes specific for the hyrdolsis of the nitrile group of bromoxynil, nucleotide sequences encoding for such enzymes, and transformed cells in which the nitrilase expression if foreign are provided. The transformed cells are capable of expressing the nitrilase enzyme to provide detoxification of an environment and protect bromoxynil-sensitive cells from its cytotoxic effect. Particularly, plants are developed which are resistant to bromoxynil.E. coli MM294 strain (pBrx5) was deposited at the A.T.C.C. on Jan. 22, 1986 and given Accession no. 53435.E. coli MM294 strain (pBrx11) was deposited at the A.T.C.C. on June 18, 1987 and given Accession no. 67441.E. coli MM294 strain (pBrx23) was deposited at the A.T.C.C. on June 18, 1987 and given Accession no. 67442.
    Type: Grant
    Filed: July 8, 1987
    Date of Patent: March 7, 1989
    Assignee: Rhone Poulenc Agrochimie
    Inventor: David M. Stalker
  • Patent number: 4788147
    Abstract: Ethanolamine in a sample can be assayed by treating the sample with ethanolamine oxidase, thereby to catalyze a reaction-consuming ethanolamine, oxygen and water, and forming glycolaldehyde, ammonia and hydrogen peroxide. The amount of consumed oxygen or the amount of generated ammonia or hydrogen peroxide is then determined, as a measure of the ethanolamine that was originally the sample. The ethanolamine can appear in the sample as such, or can be liberated simultaneously with or prior to the catalysis reaction, from an ethanolamine derivative, e.g. phosphatidyl ethanolamine by the action of phospholipase D. Ethanolamine oxidase can be produced from Bacillus sp. B-0783 FERM-P No. 5798 in a conventional culture medium, preferably by submerged aeration liquid culturation.
    Type: Grant
    Filed: May 21, 1986
    Date of Patent: November 29, 1988
    Assignee: Toyo Jozo Kabushiki Kaisha
    Inventors: Shigeyuki Imamura, Hideo Misaki
  • Patent number: 4783404
    Abstract: Yeasts of the genus cryptococcus, preferably of the species C. Laurentii, form, in the presence of aminoacids, an L-aminoacid oxidase which stereospecifically converts L-aminoacids and their derivatives into the corresponding .alpha.-ketoacids. The immobilized cells are advantageously used for this conversion, which can also be used to resolve racemates.
    Type: Grant
    Filed: September 14, 1984
    Date of Patent: November 8, 1988
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Werner Aretz, Klaus Sauber
  • Patent number: 4746606
    Abstract: An enzyme preparation having specific bilirubin degrading activity is described. It is isolated from plants (e.g. artichokes) of the Compositae family. It exhibits higher specificity towards bilirubin and has higher specific activity (i.e. turnover number of moles of substrate per minute per mg of protein) than similar enzymes isolated from other sources. Assay compositions, analytical elements and methods for use of such are also described.
    Type: Grant
    Filed: May 27, 1986
    Date of Patent: May 24, 1988
    Assignee: Eastman Kodak Company
    Inventors: Tai W. Wu, Edward R. Scalice
  • Patent number: 4745061
    Abstract: A D-aminoacid transaminase which converts CPC with .DELTA.-keto acids into .DELTA.-ketoadipinyl-7-ACA can be isolated from Bacillus Licheniformis ATCC 9945. This transamination can be applied to other D-amino acids and can also be used for the preparation of D-amino acids from .DELTA.-keto acids. The enzyme is also suitable for resolving racemates of D,L-amino acids and for detection of .DELTA.-keto acids alongside L-amino acids.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: May 17, 1988
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Werner Aretz, Klaus Sauber
  • Patent number: 4743549
    Abstract: The present invention provides a hydrogen peroxide-forming sarcosine oxidase, wherein it is obtainable from Streptomycetaceae and at 25.degree. C. in 0.15 mol/liter potassium phosphate (pH 7.9), in the presence of surface-active substances, still shows after 2 days an activity of at least 40% of the initial activity.
    Type: Grant
    Filed: May 28, 1986
    Date of Patent: May 10, 1988
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ulrich Mayr, Hans Mollering, Joachim Siedel, Hans Seidel